Neuberger Berman Group LLC Sangamo Therapeutics, Inc Transaction History

Neuberger Berman Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 14, 2024	BUY	$0.42 - $1.38 $4,446 - $14,610	10,587 New	10,587 $7,000
Q1 2024 May 13, 2024	BUY	$0.42 - $1.38 $4,446 - $14,610	10,587 New	10,587 $7,000
Q3 2023 Nov 14, 2023	BUY	$0.58 - $1.47 $8,282 - $20,993	14,281 New	14,281 $8,000
Q1 2019 May 13, 2019	SELL	$7.72 - $12.81 $115,159 - $191,086	-14,917 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$9.51 - $16.6 $31,363 - $54,746	-3,298 Reduced 18.11%	14,917 $171,000
Q3 2018 Nov 13, 2018	BUY	$13.05 - $19.05 $237,705 - $346,995	18,215 New	18,215 $309,000
Q1 2018 May 08, 2018	SELL	$16.7 - $26.35 $1.02 Million - $1.61 Million	-61,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $464,000 - $694,000	40,000 Added 190.48%	61,000 $1 Million
Q3 2017 Nov 15, 2017	BUY	$8.4 - $15.0 $176,400 - $315,000	21,000	21,000 $315,000

113

57.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $182M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.